⌘K

Login Start Free

Home/Filings/4/0001209191-21-038800

4//SEC Filing

Thomas Dolca 4

Accession 0001209191-21-038800

CIK 0001435049other

View on SEC.gov Company Profile

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 9:38 PM ET

Size

5.5 KB

Accession

0001209191-21-038800

Insider Transaction Report

Form 4

Period: 2021-06-04

CHINOOK THERAPEUTICS, INC.KDNY

Director

Transactions

Award
Stock Option (Right to Buy)
2021-06-04+5,948→ 5,948 total
Exercise: $16.81Exp: 2031-06-03→ Common Stock (5,948 underlying)

Footnotes (1)

[F1]The option award will fully vest upon the earlier of 1) the Issuer's next annual stockholder meeting, or 2) June 4, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CHINOOK THERAPEUTICS, INC.

CIK 0001435049

Entity typeother

Related Parties

1

filerCIK 0001768239

Filing Metadata

Form type: 4
Filed: Jun 6, 8:00 PM ET
Accepted: Jun 7, 9:38 PM ET
Size: 5.5 KB

View on SEC.gov